Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, epidemiology, Lymphomas, non-Hodgkin lymphoma, Non-Biological therapies, Bispecific Antibody Therapy, Clinical Research, B Cell lymphoma, Chemotherapy, Combination therapy, Diseases, indolent lymphoma, Therapies, Immunotherapy, real-world evidence, Lymphoid Malignancies, Adverse Events, registries, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Human, Minimal Residual Disease , machine learning
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, epidemiology, Lymphomas, non-Hodgkin lymphoma, Non-Biological therapies, Bispecific Antibody Therapy, Clinical Research, B Cell lymphoma, Chemotherapy, Combination therapy, Diseases, indolent lymphoma, Therapies, Immunotherapy, real-world evidence, Lymphoid Malignancies, Adverse Events, registries, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Human, Minimal Residual Disease , machine learning
Monday, December 12, 2022: 4:30 PM-6:00 PM
R06-R09
(Ernest N. Morial Convention Center)
Moderators:
Sumana Devata, MD, Medical College of Wisconsin
and
Narendranath Epperla, MD, MS, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Disclosures:
Epperla: Incyte: Speakers Bureau; Novartis: Honoraria; TG Therapeutics: Other: Ad Board; BeiGene: Other: Ad Board; Seattle Genetics: Other: Ad Board; Pharmacyclics: Other: Ad Board.
This session focuses on the studies (both clinical and epidemiological) studies pertaining to follicular lymphoma
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH